Top

Published in:

01-01-2021 | Golimumab | Case Based Review

Behcet’s disease with peripheral nervous system involvement successfully treated with golimumab: a case report and review of the literature

Authors: Menghui Yao, Congcong Gao, Chunyi Zhang, Xueqi Di, Wenfang Liang, Wenbo Sun, Qianqian Wang, Zhaohui Zheng

Published in: Rheumatology International | Issue 1/2021

Abstract

Nervous system involvement is a rare and serious complication of Behcet’s disease (BD), and the peripheral type is rarer. This article aimed to describe a case of BD with the peripheral nervous system (PNS) involvement and present a comprehensive literature review. One case of BD with PNS involvement was reported and related literature was retrospectively reviewed via PubMed/MEDLINE and Scopus database. The patient was resistant to traditional treatments, such as glucocorticoids and immunosuppressants, but had rapid quiescence after using golimumab. Our literature review suggests that the involved peripheral nerves in BD were diverse, the most common were the tibial nerves and peroneal nerves, vasculitis might be the main cause, and prednisone was still the cornerstone of treatment. TNF-α inhibitors have been increasingly used for refractory BD in recent years. This well-illustrated case demonstrates the potential benefit of golimumab to the patient with PNS involvement. Given the diversity and complexity of PNS involvement, we recommend golimumab as a new trial treatment in clinical practice.

Tong B, Liu X, Xiao J, Su G (2019) Immunopathogenesis of Behcet's Disease. Front Immunol 10:665. https://doi.org/10.3389/fimmu.2019.00665CrossRefPubMedPubMedCentral

Bilge NS, Saylisoy S, Kasifoglu T, Korkmaz C (2014) Mass-like lesions as a rare form of neuro-Behcet's disease: a case report and review of the literature. Eur J Rheumatol 1(1):34–38. https://doi.org/10.5152/eurjrheum.2014.007CrossRefPubMedPubMedCentral

Al-Araji A, Kidd DP (2009) Neuro-Behcet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8(2):192–204. https://doi.org/10.1016/s1474-4422(09)70015-8CrossRefPubMed

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kotter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H (2018) 2018 update of the EULAR recommendations for the management of Behcet's syndrome. Ann Rheum Dis 77(6):808–818. https://doi.org/10.1136/annrheumdis-2018-213225CrossRefPubMed

Santos Lacomba M, Marcos Martin C, Gallardo Galera JM, Gomez Vidal MA, Collantes Estevez E, Ramirez Chamond R, Omar M (2001) Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 33(5):251–255. https://doi.org/10.1159/000055677CrossRefPubMed

Mohan MC, Koya JM, Kandaswamy GV, Jaleel VA, Jimnaz PA, Manjuhasan S (2015) Ravindran V (2015) Neuro-Behcet’s: a diagnostic challenge. Oxf Med Case Rep 7:311–313. https://doi.org/10.1093/omcr/omv046CrossRef

Yazici H, Esen F (2008) Mortality in Behcet's syndrome. Clin Exp Rheumatol 26(5):S138–140PubMed

Chajek T, Fainaru M (1975) Behcet’s disease Report of 41 cases and a review of the literature. Medicine (Baltimore) 54(3):179–196. https://doi.org/10.1097/00005792-197505000-00001CrossRef

Koto S, Umeda M, Kawano H, Endo Y, Shimizu T, Koga T, Ichinose K, Nakamura H, Mukaino A, Higuchi O, Nakane S, Kawakami A (2020) Behçet’s disease with severe autonomic disorders developing after herpes zoster. Intern Med 59(8):1099–1104. https://doi.org/10.2169/internalmedicine.3954-19CrossRefPubMedPubMedCentral

10.

Benzakour M, Moudatir M, Echchilali K, Kitane Y, Alaoui FZ, Elkabli H (2018) Acute polyradiculoneuritis revealing Behçet’s disease. Revue Neurologique 174(7–8):573–575. https://doi.org/10.1016/j.neurol.2017.08.007CrossRefPubMed

11.

Kotan D, Alemdar M, Koksal SA (2017) A patient with Neuro-Behcet's syndrome presenting with peripheral nerve involvement. Noro Psikiyatr Ars 54(4):376–378. https://doi.org/10.5152/npa.2017.18121CrossRefPubMedPubMedCentral

12.

Cantarini L, Stromillo ML, Vitale A, Lopalco G, Emmi G, Silvestri E, Federico A, Galeazzi M, Iannone F, De Stefano N (2016) Efficacy and Safety of Intravenous Immunoglobulin Treatment in Refractory Behcet's Disease with Different Organ Involvement: A Case Series. The Israel Medical Association journal : IMAJ 18(3–4):238–242PubMed

13.

Sato T, Ouchi H, Shimbo J, Sato A, Yamazaki M, Hashidate H, Igarashi S, Kakita A (2014) Coexistence of amyotrophic lateral sclerosis with neuro-Behcet's disease presenting as a longitudinally extensive spinal cord lesion: clinicopathologic features of an autopsied patient. Neuropathology 34(2):185–189. https://doi.org/10.1111/neup.12074CrossRefPubMed

14.

Shugaiv E, Kiyat-Atamer A, Tuzun E, Deymeer F, Oflazer P, Parman Y, Akman-Demir G (2013) Coexistence of Guillain-Barre syndrome and Behcet’s disease. Clin Exp Rheumatol 31(3):88–89PubMed

15.

Eun MY, Kang CH, Kim BJ (2011) Tibial neuropathy associated with Behce’s disease. Am J Phys Med Rehabil 90(5):432–433. https://doi.org/10.1097/PHM.0b013e3181f71214CrossRefPubMed

16.

Kikuchi T, Yokoe I, Masuyama A, Maniwa K, Tsuruta S, Hatanaka Y, Haraoka H (2010) Behcet’s disease initially presenting with meningitis and sudden hearing loss. Intern Med 49(5):483–486. https://doi.org/10.2169/internalmedicine.49.2742CrossRefPubMed

17.

Menassa J, Sawaya R, Masri AF, Arayssi T (2008) Recurrent peripheral facial paresis may constitute the sole clinical manifestation in neuro-behcet disease. Neurologist 14(1):77. https://doi.org/10.1097/NRL.0b013e318159c69fCrossRefPubMed

18.

Kara M, Ozcakar L, Eken G, Ozen G, Kiraz S (2008) Deep venous thrombosis and inferior vena cava agenesis causing double crush sciatic neuropathy in Behcet's disease. Joint Bone Spine 75(6):734–736CrossRef

19.

Hatzitolios A, Savopoulos C, Ntaios G, Tsirogianni E, Baltatzi M, Apostolopoulou M, Dimitrakoudi E (2008) Recurrent peripheral facial paresis may constitute the sole clinical manifestation in neuro-behcet disease. Neurologist 14(1):77. https://doi.org/10.1097/NRL.0b013e31815879f5CrossRefPubMed

20.

Karabudak O, Dogru S, Dogan B, Harmanyeri Y (2007) Unilateral vocal cord paralysis in a patient with Behçet,s disease [12]. J Eur Acad Dermatol Venereol 21(10):1427–1428. https://doi.org/10.1111/j.1468-3083.2007.02233.xCrossRefPubMed

21.

Ben Ghorbel I, Ibnelhadj Z, Zouari M, Nagi S, Khanfir M, Hentati F, Houman MH (2005) Behcet’s disease associated with peripheral neuropathy. Rev Neurol (Paris) 161(2):218–220. https://doi.org/10.1016/s0035-3787(05)85026-xCrossRef

22.

Tsirogianni ES, Hatzitolios AI, Savopoulos CG, Baltatzi MS, Apostolopoulou MI, Magripli CM, Dimitrakoudi ET (2004) Neuro-Behcet's syndrome may present with peripheral paresis of the facial nerve. J Peripher Nerv Syst 9(2):59–61. https://doi.org/10.1111/j.1085-9489.2004.009203.xCrossRefPubMed

23.

Siepmann M, Kirch W (2003) Sensory symptoms in Behcet’s syndrome. Adv Exp Med Biol 528:383–384. https://doi.org/10.1007/0-306-48382-3_78CrossRefPubMed

24.

Pirildar T, Çelik O (2003) Sudden hoarseness due to unilateral cord vocal paralysis in a patient with Behçet's disease. Clin Rheumatol 22(3):254–255. https://doi.org/10.1007/s10067-003-0708-3CrossRefPubMed

25.

Duran E, Chacon JR (2001) Behcet’s disease with atypical double neurological involvement. Rev Neurol 33(4):333–334PubMed

26.

Lew H, Lee JB, Han SH, Kim HS, Kim SK (1999) Neuro-Behcet’s disease presenting with isolated unilateral lateral rectus muscle palsy. Yonsei Med J 40(3):294–296. https://doi.org/10.3349/ymj.1999.40.3.294CrossRefPubMed

27.

Lee KY, Sunwoo IN, Oh WS, Kim SM, Choi BO (1999) Brachial plexopathy caused by subclavian artery aneurysm in Behçet's disease. Muscle Nerve 22(12):1721–1723. https://doi.org/10.1002/(sici)1097-4598(199912)22:12<1721:aid-mus17>3.0.co;2-wCrossRefPubMed

28.

Ko KF, Kwan MC, Chan TP, Kay CS, Lam EK (1997) Isolated hypoglossal nerve palsy in Behcet's disease. Ann Acad Med Singapore 26(6):848–849PubMed

29.

Gallinaro C, Robinet-Combes A, Sale Y, Richard P, Saraux A, Colin J (1995) Neuropapillitis in Behcet disease. A case. J Fr Ophtalmol 18(2):147–150PubMed

30.

Walker LJ, Swallow MW, Mirakhur M (1990) Behcet’s disease presenting with mononeuritis multiplex [corrected]. Ulster Med J 59(2):206–210PubMedPubMedCentral

31.

Tsubata T, Kumagai S, Ishida H, Umehara H, Ishikawa K, Imura H, Saida K, Suginoshita T (1989) A case of Behcet's disease with mononeuritis multiplex due to vasculitis. Japn J Clin Immunol 12(1):135–141. https://doi.org/10.2177/jsci.12.135CrossRef

32.

Takeuchi A, Kodama M, Takatsu M, Hashimoto T, Miyashita H (1989) Mononeuritis multiplex in incomplete Behçet’s disease: a case report and the review of the literature. Clin Rheumatol 8(3):375–380. https://doi.org/10.1007/bf02030351CrossRefPubMed

33.

Gulturk S, Akyol M, Kececi H, Ozcelik S, Cinar Z, Demirkazik A (2008) Delayed habituation in Behcet’s disease. Neurol India 56(1):27–30. https://doi.org/10.4103/0028-3886.39308CrossRefPubMed

34.

Atasoy HT, Tunc TO, Unal AE, Emre U, Koca R, Esturk E, Inan LE (2007) Peripheral nervous system involvement in patients with Behcet disease. Neurologist 13(4):225–230. https://doi.org/10.1097/NRL.0b013e31805778d1CrossRefPubMed

35.

Akbulut L, Gur G, Bodur H, Alli N, Borman P (2007) Peripheral neuropathy in Behcet disease: an electroneurophysiological study. Clin Rheumatol 26(8):1240–1244. https://doi.org/10.1007/s10067-006-0466-0CrossRefPubMed

36.

Tataroglu C, Tursen U, Unal O, Kaya TI (2004) Long-latency reflexes in patients with Behcet’s disease. J Neurol Sci 220(1–2):67–71. https://doi.org/10.1016/j.jns.2004.02.005CrossRefPubMed

37.

Birol A, Ulkatan S, Kocak M, Erkek E (2004) Peripheral neuropathy in Behcet’s disease. J Dermatol 31(6):455–459. https://doi.org/10.1111/j.1346-8138.2004.tb00531.xCrossRefPubMed

38.

Budak F, Efendi H, Apaydin R, Bilen N, Komsuoglu S (2000) The F response parameters in Behcet’s disease. Electromyogr Clin Neurophysiol 40(1):45–48PubMed

39.

Moore PM, Cupps TR (1983) Neurological complications of vasculitis. Ann Neurol 14(2):155–167. https://doi.org/10.1002/ana.410140202CrossRefPubMed

40.

Zhou ZY, Chen SL, Shen N, Lu Y (2012) Cytokines and Behcet’s disease. Autoimmun Rev 11(10):699–704. https://doi.org/10.1016/j.autrev.2011.12.005CrossRefPubMed

41.

Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, Tsuji T, Ueda A, Nakamura S, Ohno S, Ishigatsubo Y (2003) Cytokine production profile in patients with Behcet’s disease treated with infliximab. Cytokine 24(5):210–218. https://doi.org/10.1016/j.cyto.2003.09.003CrossRefPubMed

42.

El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, Geboes K, Van Damme J (2011) Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 139(2):177–184. https://doi.org/10.1016/j.clim.2011.01.014CrossRefPubMed

43.

Siva A, Hirohata S (2010) Behçet's syndrome and the nervous system. Behçet's Syndrome 1:95–113. https://doi.org/10.1007/978-1-4419-5641-5_6CrossRef

Title: Behcet’s disease with peripheral nervous system involvement successfully treated with golimumab: a case report and review of the literature
Authors: Menghui Yao
Congcong Gao
Chunyi Zhang
Xueqi Di
Wenfang Liang
Wenbo Sun
Qianqian Wang
Zhaohui Zheng
Publication date: 01-01-2021
Publisher: Springer Berlin Heidelberg
Keyword: Golimumab
Published in: Rheumatology International / Issue 1/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-020-04650-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Behcet’s disease with peripheral nervous system involvement successfully treated with golimumab: a case report and review of the literature

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

The influence of carrying MEFV gene variants on juvenile systemic lupus erythematosus

Response to ‘How to define disease severity accurately in patients with familial Mediterranean fever’

Protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever in children: case-based review

COVID-19 pandemic in Japan

Comorbidities and phenotype–genotype correlation in children with familial Mediterranean fever

Optic neuritis as a presenting feature of Behçet’s disease: case-based review

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page